These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9448564)

  • 1. Osteoporosis in men.
    Galus M
    Arch Intern Med; 1998 Jan; 158(2):194. PubMed ID: 9448564
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of osteoporosis in men treated for prostate cancer.
    Oefelein MG; Resnick MI
    Urol Clin North Am; 2004 May; 31(2):313-9. PubMed ID: 15123410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer].
    Eiken PA; Langdahl BL; Eiken FL; Walter S; Poulsen MH; Abrahamsen B
    Ugeskr Laeger; 2011 Nov; 173(48):3093-6. PubMed ID: 22118650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing and treating the complications of hormone therapy.
    Kumar RJ; Barqawi A; Crawford ED
    Curr Urol Rep; 2005 May; 6(3):217-23. PubMed ID: 15869726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone and Men's Health. Hormonal therapy and bone loss in prostate cancer].
    Izumi K; Mizokami A; Namiki M
    Clin Calcium; 2010 Feb; 20(2):175-81. PubMed ID: 20118508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual zoledronic acid: is less more?
    Higano CS
    J Clin Oncol; 2007 Mar; 25(9):1026. PubMed ID: 17369565
    [No Abstract]   [Full Text] [Related]  

  • 8. [Loss of bone mass in patients with prostate cancer subjected to androgenic deprivation].
    Morote J; Planas J
    Actas Urol Esp; 2011 Apr; 35(4):232-9. PubMed ID: 21419516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Diethylstilbesterol revised: androgen deprivation, osteoporosis and prostate cancer.
    Pitts WR
    J Urol; 2002 Nov; 168(5):2131-2. PubMed ID: 12394735
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer treated with androgen deprivation therapy has consequences for bone.
    Adler RA
    Endocrine; 2014 Apr; 45(3):339-40. PubMed ID: 24366636
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Osteoporosis after orchiectomy for prostate cancer.
    Krongrad A; Levis S; Roos BA
    J Urol; 1997 Oct; 158(4):1529-30. PubMed ID: 9302165
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden.
    Thorstenson A; Bratt O; Akre O; Hellborg H; Holmberg L; Lambe M; Bill-Axelson A; Stattin P; Adolfsson J
    Eur J Cancer; 2012 Jul; 48(11):1672-81. PubMed ID: 22386317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease associated with androgen-deprivation therapy: time to give it due respect.
    Basaria S
    J Clin Oncol; 2015 Apr; 33(11):1232-4. PubMed ID: 25753444
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hot flushes in men after surgical or pharmacologic castration].
    Aubert J; Vigouroux V; Doré B
    Prog Urol; 1995 Sep; 5(4):507-9. PubMed ID: 7581499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer.
    Barrass BJ; Thurairaja R; Persad RA
    BJU Int; 2004 Jun; 93(9):1175-6. PubMed ID: 15180599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Osteoporosis in castration therapy--a neglected field].
    Bratt O; Akesson K
    Lakartidningen; 2011 Sep 28-Oct 4; 108(39):1902-5. PubMed ID: 22111227
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
    Wu CT; Yang YH; Chen PC; Chen MF; Chen WC
    Osteoporos Int; 2015 Sep; 26(9):2281-90. PubMed ID: 25990353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive osteoporosis during androgen deprivation therapy for prostate cancer.
    Daniell HW; Dunn SR; Ferguson DW; Lomas G; Niazi Z; Stratte PT
    J Urol; 2000 Jan; 163(1):181-6. PubMed ID: 10604342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture for hot flashes in men treated with androgen deprivation therapy.
    Hirsch LM; Goldstein LE
    Can J Urol; 2015 Aug; 22(4):7938-41. PubMed ID: 26267037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deprivation therapy for localized and nonmetastatic prostate cancer: too much of a good thing?
    Konijeti R; Kibel AS
    Eur Urol; 2012 Jun; 61(6):1129-30; discussion 1131. PubMed ID: 22445550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.